Maureen Menwa Achebe, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anemia, Sickle Cell | 17 | 2021 | 1065 | 2.390 |
Why?
|
Anemia, Iron-Deficiency | 10 | 2023 | 372 | 1.550 |
Why?
|
Hematinics | 4 | 2020 | 282 | 1.480 |
Why?
|
Ferric Compounds | 7 | 2022 | 377 | 1.290 |
Why?
|
Antisickling Agents | 4 | 2019 | 72 | 0.870 |
Why?
|
Hydroxyurea | 5 | 2019 | 284 | 0.840 |
Why?
|
Disaccharides | 5 | 2022 | 170 | 0.780 |
Why?
|
Pregnancy Complications, Hematologic | 3 | 2017 | 183 | 0.750 |
Why?
|
Death, Sudden | 1 | 2019 | 301 | 0.580 |
Why?
|
Glucaric Acid | 2 | 2017 | 10 | 0.560 |
Why?
|
Iron | 4 | 2023 | 1813 | 0.560 |
Why?
|
Leukocyte Count | 1 | 2021 | 1609 | 0.540 |
Why?
|
Hemoglobins | 8 | 2022 | 1531 | 0.490 |
Why?
|
Vitamin B Complex | 1 | 2016 | 299 | 0.470 |
Why?
|
Vitamin B 12 | 1 | 2016 | 528 | 0.440 |
Why?
|
Hemoglobin, Sickle | 4 | 2021 | 113 | 0.440 |
Why?
|
Maltose | 2 | 2020 | 39 | 0.420 |
Why?
|
Iron-Dextran Complex | 1 | 2012 | 14 | 0.420 |
Why?
|
Adenosine A2 Receptor Agonists | 2 | 2013 | 31 | 0.410 |
Why?
|
Anemia | 2 | 2016 | 1516 | 0.370 |
Why?
|
Drug Hypersensitivity | 1 | 2020 | 923 | 0.370 |
Why?
|
Pyrazoles | 4 | 2021 | 2029 | 0.360 |
Why?
|
Benzaldehydes | 2 | 2021 | 59 | 0.350 |
Why?
|
Folic Acid | 1 | 2016 | 1336 | 0.340 |
Why?
|
Natural Killer T-Cells | 2 | 2013 | 318 | 0.320 |
Why?
|
Purines | 2 | 2013 | 615 | 0.320 |
Why?
|
Fetal Hemoglobin | 2 | 2020 | 346 | 0.310 |
Why?
|
Sickle Cell Trait | 2 | 2019 | 86 | 0.310 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2015 | 778 | 0.310 |
Why?
|
Neutrophils | 1 | 2021 | 3785 | 0.300 |
Why?
|
Ferrous Compounds | 1 | 2017 | 41 | 0.290 |
Why?
|
Drug Approval | 1 | 2014 | 820 | 0.280 |
Why?
|
Patient Readmission | 1 | 2020 | 3313 | 0.250 |
Why?
|
Pyrazines | 2 | 2021 | 1206 | 0.230 |
Why?
|
Ferritins | 1 | 2017 | 600 | 0.230 |
Why?
|
Hypophosphatemia | 2 | 2022 | 93 | 0.210 |
Why?
|
Receptor, Adenosine A2A | 1 | 2013 | 129 | 0.200 |
Why?
|
Hydroxamic Acids | 1 | 2015 | 483 | 0.200 |
Why?
|
Administration, Oral | 2 | 2017 | 4042 | 0.190 |
Why?
|
Endothelium-Dependent Relaxing Factors | 1 | 2011 | 21 | 0.190 |
Why?
|
IgA Deficiency | 1 | 2011 | 39 | 0.190 |
Why?
|
Thymus Hyperplasia | 1 | 2011 | 32 | 0.180 |
Why?
|
Duffy Blood-Group System | 1 | 2021 | 61 | 0.180 |
Why?
|
gamma-Globins | 1 | 2020 | 105 | 0.170 |
Why?
|
Ikaros Transcription Factor | 1 | 2011 | 233 | 0.160 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2011 | 235 | 0.150 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 752 | 0.150 |
Why?
|
Acute Chest Syndrome | 2 | 2020 | 32 | 0.140 |
Why?
|
Arterial Occlusive Diseases | 1 | 2021 | 746 | 0.140 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2017 | 96 | 0.140 |
Why?
|
Folic Acid Deficiency | 1 | 2016 | 117 | 0.130 |
Why?
|
Adult | 23 | 2022 | 223818 | 0.130 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2016 | 119 | 0.130 |
Why?
|
Anaphylaxis | 1 | 2023 | 758 | 0.130 |
Why?
|
Bone Marrow Diseases | 1 | 2017 | 234 | 0.120 |
Why?
|
Anemia, Aplastic | 1 | 2017 | 231 | 0.120 |
Why?
|
Albuminuria | 1 | 2018 | 658 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2013 | 1162 | 0.120 |
Why?
|
Hospitalization | 1 | 2014 | 10845 | 0.110 |
Why?
|
Glomerular Filtration Rate | 2 | 2019 | 2228 | 0.110 |
Why?
|
Reference Values | 1 | 2021 | 4941 | 0.110 |
Why?
|
Length of Stay | 2 | 2020 | 6525 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2022 | 10397 | 0.110 |
Why?
|
Female | 25 | 2021 | 397464 | 0.110 |
Why?
|
Humans | 35 | 2023 | 768887 | 0.100 |
Why?
|
Bone Marrow Transplantation | 1 | 2020 | 2709 | 0.100 |
Why?
|
Adolescent | 12 | 2021 | 89247 | 0.100 |
Why?
|
Phospholipases A2, Secretory | 1 | 2012 | 30 | 0.100 |
Why?
|
RNA Interference | 1 | 2020 | 2835 | 0.100 |
Why?
|
Nitric Oxide | 1 | 2011 | 2149 | 0.100 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1514 | 0.100 |
Why?
|
Erythrocyte Transfusion | 1 | 2016 | 575 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2011 | 2211 | 0.100 |
Why?
|
Male | 21 | 2021 | 365249 | 0.090 |
Why?
|
Injections, Intravenous | 1 | 2012 | 1379 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2020 | 2986 | 0.080 |
Why?
|
Child, Preschool | 5 | 2020 | 42684 | 0.080 |
Why?
|
Multicenter Studies as Topic | 2 | 2022 | 1737 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6546 | 0.080 |
Why?
|
Acute Disease | 1 | 2020 | 7245 | 0.080 |
Why?
|
Child | 9 | 2021 | 80969 | 0.080 |
Why?
|
Young Adult | 10 | 2021 | 60110 | 0.080 |
Why?
|
Middle Aged | 14 | 2021 | 223740 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2019 | 2297 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2018 | 2100 | 0.070 |
Why?
|
Infusions, Intravenous | 2 | 2013 | 2231 | 0.070 |
Why?
|
Insurance, Health | 1 | 2020 | 2518 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2011 | 4794 | 0.070 |
Why?
|
Medicaid | 1 | 2020 | 2843 | 0.070 |
Why?
|
Health Care Costs | 1 | 2020 | 3270 | 0.070 |
Why?
|
Pregnancy Outcome | 1 | 2017 | 2957 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3233 | 0.070 |
Why?
|
Age Factors | 2 | 2020 | 18454 | 0.070 |
Why?
|
United States Food and Drug Administration | 1 | 2014 | 1672 | 0.060 |
Why?
|
Pain | 1 | 2011 | 5100 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2020 | 5369 | 0.060 |
Why?
|
United States | 6 | 2020 | 73180 | 0.060 |
Why?
|
Infant | 4 | 2020 | 36541 | 0.060 |
Why?
|
Telemedicine | 1 | 2023 | 3109 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12563 | 0.060 |
Why?
|
Treatment Outcome | 8 | 2022 | 65485 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2021 | 10778 | 0.060 |
Why?
|
Retrospective Studies | 4 | 2019 | 81892 | 0.060 |
Why?
|
Pregnancy | 4 | 2018 | 30175 | 0.060 |
Why?
|
Time Factors | 3 | 2020 | 40266 | 0.060 |
Why?
|
Incidence | 4 | 2023 | 21545 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2965 | 0.050 |
Why?
|
Headache | 2 | 2021 | 1263 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39394 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2021 | 12469 | 0.050 |
Why?
|
Transcription Factor RelA | 1 | 2013 | 254 | 0.050 |
Why?
|
Aged | 6 | 2021 | 171790 | 0.050 |
Why?
|
Plasma Volume | 1 | 2011 | 32 | 0.050 |
Why?
|
Hookworm Infections | 1 | 2011 | 17 | 0.050 |
Why?
|
Pregnancy Complications, Parasitic | 1 | 2011 | 62 | 0.050 |
Why?
|
Fatigue | 1 | 2017 | 1557 | 0.040 |
Why?
|
Thymoma | 1 | 2011 | 191 | 0.040 |
Why?
|
Pneumothorax | 1 | 2003 | 393 | 0.040 |
Why?
|
P-Selectin | 1 | 2021 | 599 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12093 | 0.040 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2011 | 259 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2013 | 2299 | 0.040 |
Why?
|
Polymerization | 1 | 2019 | 155 | 0.040 |
Why?
|
Risk Factors | 3 | 2020 | 74971 | 0.040 |
Why?
|
Thymus Neoplasms | 1 | 2011 | 277 | 0.040 |
Why?
|
Menorrhagia | 1 | 2018 | 59 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 417 | 0.040 |
Why?
|
Lactation Disorders | 1 | 2017 | 14 | 0.040 |
Why?
|
Demography | 1 | 2023 | 1643 | 0.040 |
Why?
|
Administration, Inhalation | 1 | 2011 | 1169 | 0.040 |
Why?
|
Cell Count | 1 | 2012 | 1833 | 0.040 |
Why?
|
Hemolysis | 1 | 2019 | 417 | 0.030 |
Why?
|
Placebo Effect | 1 | 2021 | 518 | 0.030 |
Why?
|
Nausea | 1 | 2020 | 682 | 0.030 |
Why?
|
Drug Dosage Calculations | 1 | 2017 | 117 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2017 | 575 | 0.030 |
Why?
|
Phosphates | 1 | 2020 | 765 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1608 | 0.030 |
Why?
|
Remission Induction | 1 | 2012 | 2411 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2126 | 0.030 |
Why?
|
Fetal Death | 1 | 2017 | 434 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2003 | 1376 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2357 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2013 | 3163 | 0.030 |
Why?
|
Dietary Supplements | 1 | 2017 | 3442 | 0.030 |
Why?
|
Down-Regulation | 1 | 2020 | 2941 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15662 | 0.030 |
Why?
|
Prospective Studies | 3 | 2023 | 54950 | 0.030 |
Why?
|
Abortion, Spontaneous | 1 | 2017 | 534 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2013 | 5905 | 0.020 |
Why?
|
Telomerase | 1 | 2017 | 753 | 0.020 |
Why?
|
Registries | 2 | 2019 | 8384 | 0.020 |
Why?
|
Phosphorylation | 1 | 2013 | 8317 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2011 | 2574 | 0.020 |
Why?
|
Bariatric Surgery | 1 | 2022 | 1001 | 0.020 |
Why?
|
Quality of Life | 2 | 2018 | 13510 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3433 | 0.020 |
Why?
|
Pre-Eclampsia | 1 | 2011 | 1251 | 0.020 |
Why?
|
Infertility, Female | 1 | 2017 | 764 | 0.020 |
Why?
|
Malaria | 1 | 2011 | 1241 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2020 | 3414 | 0.020 |
Why?
|
Pain Measurement | 1 | 2011 | 3585 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6320 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2915 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 3048 | 0.020 |
Why?
|
Prognosis | 2 | 2013 | 30044 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2017 | 59738 | 0.020 |
Why?
|
RNA | 1 | 2017 | 2727 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 41800 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8742 | 0.020 |
Why?
|
Sepsis | 1 | 2011 | 2609 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 13048 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8055 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2011 | 14485 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2023 | 5520 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2013 | 22294 | 0.010 |
Why?
|
Sex Factors | 1 | 2019 | 10641 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15875 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8745 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5323 | 0.010 |
Why?
|
Animals | 2 | 2012 | 169408 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2003 | 13593 | 0.010 |
Why?
|
Signal Transduction | 1 | 2011 | 23652 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 24330 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 26394 | 0.010 |
Why?
|
Mutation | 1 | 2011 | 30266 | 0.010 |
Why?
|
HIV Infections | 1 | 2011 | 17589 | 0.010 |
Why?
|
Mice | 1 | 2011 | 82074 | 0.010 |
Why?
|
Biopsy | 1 | 2003 | 6805 | 0.010 |
Why?
|
Recurrence | 1 | 2003 | 8512 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2003 | 13020 | 0.000 |
Why?
|